The cytokine/chemokine milieu suggests that disease severity in post-CHIKV arthritis is driven by processes such as IL-6-mediated inflammation and TNF-mediated T-cell chemotaxis, in addition to an immunomodulatory response from IL-10 in an attempt to regulate immune-related damage. This evidence concerns the gene IL6 and arthritic joint disease.